Week 502 Review - A mixed week but ended in the black.

A mixed week, with small gains in my larger holdings but some big losses too. The result was a narrowing of the deficit between cost and value by £2,750 to £123,554 and a narrowing of the deficit between injection amount and value to £50,749 and increase in portfolio value to £117,055.

The biggest loser was FXPO:Ferrexpo which seems to be getting screwed over by the Ukrainian government due to the behaviour of their ex-CEO. They dropped 22% and are now 87% down.

PBX:Probiotix Health had a bad week last week and another bad week this week, dropping 11% for no reason other than no new news.

TRX:Tissue Regenix continue their relentless plummet and dropped another 10% this week to go 74% down, meaning any buy-out is going to be for practically nothing.

SBTX:SkinBioTherapeutics have had a good few weeks but I think there was some profit taking this week, as the price dropped 8%.

FOUR:4imprint continue to be hammered despite good results and dropped another 5% this week. I will be buying more when my pension transfer comes through.

Gold continued to ride high, but PAF:Pan African Resources had a bad start to the week as an institutional investor sold their entire holding via a placing and severely damaged the share price. A late rally saw it increase by 5% in the end, with my holding now 40% up.

CAML:Central Asia Metals benefitted from a rise in copper and good results, and went up 6% but they are still a long way down on what they are worth.

OPTI:Optibiotix gave a great trading update and went up 6%, but that's only a rise of 1p, when in the old days you could expect a 10p rise for something like that.

CWR:Ceres Power have been clobbered lately but recovered 11% this week. They are still 70% down and I'm worried about them.

SCT:Softcat had a good trading update beating expectations and went up 11% so my holding is within a whisker of going into profit and only down by commission.

FDM:FDM Group said there are signs of recovery and went up an impressive 15%, but my holding is still down by 22% after the last few months of misery.

Share of the Week is TLOU:Tlou Energy which went up 208% after dropping dramatically for the last few weeks. I really don't know what's going on, but it does mean my holding is only 12% down and with electricity production not that far away I'm hopeful this will eventually go into profit.

Here's the ISA and shares portfolio after week 34 of year 10.

			Weekly Change
Cash	£48.02		+£0
Portfolio cost	£114,352.47		+£0
Portfolio sell value (bid price-commission)	£48,178.00	(-57.9%)	+£1,488.49
Potential profits	£58.72		-£450.54
Yr 10 Dividends	£109.23		+£0
Yr 10 Interest	£0.82		+£0
Yr 10 Profit from sales	£327.55		+£0
Yr 10 proj avg monthly profit	£47.36	(0.7%)	-£1.43
Total Dividends	£12,417.18		+£0
Total Interest	£7.62		+£0
Total Profit from sales	£17,602.85		+£0
Average monthly cash profit	£254.59	(3.6%)	-£0.51
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	35%		+0%

Very little happened. Decent rise in value but nearly all potential profits wiped out by the drop in SBTX:SkinBioTherapeutics.

Looking fairly flat for a few months now.

Still above the trend line, but really need to return to the level around week 478 to turn it around.

The SIPP looks like this after week 486 overall and week 18 of year 10.

			Weekly Change
Cash	£260.53		+£203.27
Portfolio cost	£126,257.05		+£0
Portfolio sell value (bid price - commission)	£68,877.47	(-45.4%)	+£1,262.00
Potential profits	£3,820.53		+£107.16
Yr 10 Dividends	£532.86		+£103.27
Yr 10 Interest	£1.25		+£0
Yr 10 Profit from sales	£2,375.87		+£0
Yr 10 proj avg monthly profit	£681.03	(9.9%)	-£13.75
Total Dividends	£16,649.51		+£103.27
Total Interest	£14.15		+£0
Total Profit from sales	£19,383.81		+£0
Average monthly cash profit	£308.37	(4.5%)	+£0.28
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	42%		+0%

Cash went up thanks to a tax rebate and £103 dividend from IPX:Impax Asset Management. That's a hell of a dividend! Potential profits rose by £107 thanks only to PAF:Pan African Resources as most profitable shares dropped in value. The dividend was big enough for long term performance to go up a little.

The gap to injection amount just won't get any narrower.

Pretty much on the trend line. Better than being below it, but a similar problem to the ISA that I need to get above the level from week 452.

JLP:Jubilee Metals went up by 4% this week. Not enough to make the headlines, and just a 0.15p rise. However it's enough to put some of my SIPP holdings within 10% of profit, although my biggest ISA holding is still down by 44%. The fact it went up instead of relentlessly down could point to the institutional sellers having finished. Results are expected next week so I will be holding my breath as there's a risk they will be quite bad, but a possibility they will include a production update for copper at Roan. Something significant is likely to happen but I don't know in which direction.